Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Interpretation, Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Collaborating With Health System Partners to Review and Understand Trial Results
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Introduction

CHAPTER SECTIONS

Identifying Those Engaged in Research


Section 1

Introduction

ExpandContributors

Pearl O’Rourke, MD
Benjamin S. Wilfond, MD

Contributing Editors

Karen Staman, MS
Damon M. Seils, MA

Clinical research involves people in a variety of ways. In addition to the well-recognized roles of researcher and research participant or subject, there may be service providers and others who are affected by the research but who are neither researchers nor subjects. Examples include family members, other patients, and clinical staff. Pragmatic clinical trials conducted in settings of routine clinical care can involve a variety of roles beyond the researcher and the subject roles and can present a challenge in identifying who is properly considered a subject.

In this chapter, we differentiate between researchers, research participants, service providers, and those affected by the research, and we describe the appropriate mechanisms of oversight for each role.

We also note that the term "engaged" in clinical research has a regulatory meaning and is reserved for researchers and institutions that meet specific criteria relevant to the research, as described in Section 3.

Next Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction
  2. Human Subjects/Research Participants and Others Affected by the Research
  3. Identifying Those Involved in the Process of the Research
  4. Clinicians’ Duty to Participate in Pragmatic Research
  5. Case Studies From PRISM NIH Collaboratory Trials

Resources

Differentiating Between RCTs, PCTs, and Quality Improvement Activities

As discussed in this section of the Living Textbook, quality improvement activities, pragmatic clinical trials, and explanatory randomized controlled trials may involve different mechanisms for oversight and consent (Faden et al 2013; Finkelstein et al 2015).


Version History

November 3, 2026: Made nonsubstantive edits for style and clarity as part of the biennial review (changes made by D. Seils).

July 7, 2023: Made nonsubstantive changes to the Resources sidebar (changes made by D. Seils).

Published September 21, 2022

current section :

Introduction

  1. Introduction
  2. Human Subjects/Research Participants and Others Affected by the Research
  3. Identifying Those Involved in the Process of the Research
  4. Clinicians’ Duty to Participate in Pragmatic Research
  5. Case Studies From PRISM NIH Collaboratory Trials

Citation:

O’Rourke P, Wilfond BS. Identifying Those Engaged in Research: Introduction. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/ethics-and-regulatory/identifying-those-engaged-in-research/introduction/. Updated November 3, 2026. DOI: 10.28929/166.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map